What is he best known for?
The fields of study he is best known for:
David B. Weiner mostly deals with Virology, Immunology, Immune system, DNA vaccination and Antigen.
The Virology study combines topics in areas such as Humoral immunity, Antibody and HIV vaccine.
His Immune system research incorporates themes from Cytotoxic T cell and In vivo.
David B. Weiner has included themes like Adjuvant, Electroporation, Cytokine and Immunogenicity in his DNA vaccination study.
His Antigen study which covers Biochemistry that intersects with Monoclonal antibody.
His research investigates the connection between Virus and topics such as Cell culture that intersect with problems in Myosin.
His most cited work include:
- Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors (920 citations)
- DNA vaccines: ready for prime time? (716 citations)
- Gene inoculation generates immune responses against human immunodeficiency virus type 1. (681 citations)
What are the main themes of his work throughout his whole career to date?
David B. Weiner focuses on Virology, Immunology, Immune system, DNA vaccination and Antigen.
His studies examine the connections between Virology and genetics, as well as such issues in Antibody, with regards to Molecular biology and Recombinant DNA.
His research brings together the fields of Cytotoxic T cell and Immunology.
His Immune system study integrates concerns from other disciplines, such as Immunogen and Cytokine.
His DNA vaccination research includes themes of HIV vaccine, Immunogenicity, Viral vector, Electroporation and Lentivirus.
His studies deal with areas such as Cancer research and Nucleic acid as well as Antigen.
He most often published in these fields:
- Virology (49.79%)
- Immunology (43.55%)
- Immune system (42.58%)
What were the highlights of his more recent work (between 2013-2021)?
- Virology (49.79%)
- Immune system (42.58%)
- DNA vaccination (33.15%)
In recent papers he was focusing on the following fields of study:
David B. Weiner mainly focuses on Virology, Immune system, DNA vaccination, Immunology and Antigen.
His Virology research integrates issues from Plasmid and Antibody, Immunization.
His work deals with themes such as Recombinant DNA and Microbiology, which intersect with Antibody.
His study in Immune system is interdisciplinary in nature, drawing from both Cytotoxic T cell and Cancer research.
David B. Weiner combines subjects such as Immunogen, Electroporation, Immunity and Immunogenicity with his study of DNA vaccination.
His biological study spans a wide range of topics, including Nucleic acid molecule, Nucleic acid and Dysplasia.
Between 2013 and 2021, his most popular works were:
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. (339 citations)
- A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates (157 citations)
- Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report. (149 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Immunology, Virology, Immune system, DNA vaccination and Antibody.
He studied Immunology and Human morbidity that intersect with Subclinical infection, Human cytomegalovirus, Heart disease and Organ transplantation.
His study explores the link between Virology and topics such as Recombinant DNA that cross with problems in HIV vaccine.
His research on Immune system often connects related topics like Antigen.
David B. Weiner has researched DNA vaccination in several fields, including Immune tolerance, Immunity, Viral Vaccine, Vaccination and Immunogen.
His Antibody research includes elements of Immune checkpoint and Microbiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
